Price range: $355.00 through $8,155.00
Looking to buy Liraglutide for your research? Our lab-verified >98% pure Liraglutide peptide is trusted by researchers worldwide for metabolic, glycemic control, and obesity research studies. In stock – ready to ship within 24 hours.
✅ Lab-Tested >98% Purity (COA Included)
✅ GLP-1 Receptor Agonist
✅ Long-Acting Peptide
✅ Fast, Discreet Shipping Worldwide
✅ Trusted by Leading Research Institutions
Liraglutide (also known as NNC 90-1170 or NN2211) is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. It is a 31-amino-acid peptide engineered with a fatty acid side chain that provides extended half-life and once-daily dosing capability.
When you buy Liraglutide from Mega Protide, you’re getting a research-grade peptide that has been third-party tested for purity and potency. This Liraglutide research peptide is widely used in metabolic, glycemic control, and obesity research.
| Parameter | Details |
|---|---|
| Sequence | 31-amino-acid GLP-1 analog with C16 fatty acid side chain |
| Molecular Formula | C₁₇₂H₂₆₅N₄₃O₅₁ |
| Molecular Weight | ~3751.25 g/mol |
| CAS Number | 204656-20-2 |
| Synonyms | NNC 90-1170, NN2211, Saxenda®, Victoza® |
| Form | Lyophilized powder |
| Quantity | 5mg or 10mg per vial |
| Purity | >98% by HPLC |
| Solubility | H₂O: 5 mg/mL (1.33 mM) |
| Target | GLP-1 Receptor |
| Receptor | GLP-1R |
| Storage | Store at -20°C (stable ≥2 years) |
| Shipping | Ice pack |
Liraglutide exerts its effects through GLP-1 receptor activation:
| Mechanism | Effect |
|---|---|
| GLP-1 Receptor Binding | Binds to and activates GLP-1 receptors on pancreatic beta-cells |
| Insulin Secretion | Stimulates glucose-dependent insulin secretion |
| Glucagon Suppression | Inhibits inappropriate glucagon release from pancreatic alpha-cells |
| Gastric Emptying | Slows gastric emptying, promoting satiety |
| Appetite Regulation | Reduces food intake through central nervous system effects |
| Lipidated Stability | C16 fatty acid side chain extends half-life through albumin binding |
Key Advantage: Liraglutide is a long-acting GLP-1 receptor agonist with a half-life of ~13 hours, supporting once-daily dosing in research protocols.
| Application | Research Focus | Status |
|---|---|---|
| Type 2 Diabetes | Glycemic control, insulin secretion, glucagon suppression | FDA-approved (Victoza®) |
| Obesity Research | Appetite regulation, weight reduction, energy expenditure | FDA-approved (Saxenda®) |
| Cardiovascular Research | CV risk reduction in high-risk patients | FDA-approved |
| Metabolic Research | Insulin sensitivity, lipid metabolism, energy balance | Extensive research |
| Neuroprotection | Neuroprotective effects in neurodegenerative models | Active research |
| MASLD/MASH Research | Hepatic fat reduction, inflammation modulation | Active research |
| Parameter | Finding |
|---|---|
| Glycemic Control | Significantly reduces HbA1c in type 2 diabetes models |
| Weight Reduction | Dose-dependent weight loss in obesity research |
| GLP-1 Receptor Binding | Long-acting GLP-1 receptor agonist |
| Half-Life | ~13 hours (once-daily dosing) |
| Fatty Acid Modification | C16 fatty acid side chain provides extended half-life |
| Cardiovascular Benefit | Reduces cardiovascular risk in high-risk patients |
| Satiety Effect | Promotes sustained fullness and reduced caloric intake |
| Study | Year | Finding |
|---|---|---|
| Bode B, et al. | 2011 | Liraglutide showed efficacy in glycemic control in type 2 diabetes (Am J Manag Care) |
| LEAD Trials | 2008-2012 | Demonstrated superiority over other diabetes medications |
| SCALE Trials | 2014-2016 | Liraglutide (3.0 mg) showed significant weight reduction in obesity |
| LEADER Trial | 2016 | Liraglutide reduced major adverse cardiovascular events in high-risk patients |
| Neuroprotection Studies | 2020+ | Emerging research on neuroprotective effects |
📖 Over 15 years of peer-reviewed research support Liraglutide research utility.
Add 1-2ml bacteriostatic water to the Liraglutide vial
Gently swirl – do not shake
Refrigerate at 2-8°C
Use within 30 days of reconstitution
| Solvent | Concentration |
|---|---|
| H₂O | 5 mg/mL (1.33 mM) |
| Bacteriostatic Water | 5 mg/mL |
| Parameter | Recommendation |
|---|---|
| Research Dose (Rodent) | 0.1-1.0 mg/kg |
| Clinical Dose (Human) | 0.6-3.0 mg once daily |
| Frequency | Once daily |
| Route | Subcutaneous injection |
| Half-Life | ~13 hours |
| Storage | -20°C (long-term); 2-8°C after reconstitution |
| Stability | ≥2 years (lyophilized) |
| Parameter | Details |
|---|---|
| Storage (Lyophilized) | -20°C (stable ≥2 years) |
| Storage (Reconstituted) | 2-8°C, use within 30 days |
| Shipping | Ice pack |
| Centrifugation Note | Small volumes may become entrapped in seal; briefly centrifuge if needed |
| Special Handling | Some products may require dry ice shipping |
| Aspect | Details |
|---|---|
| Boxed Warning | Risk of thyroid C-cell tumors (rodent studies); relevance to humans unknown |
| Contraindications | Personal/family history of MTC, MEN 2, hypersensitivity |
| Common Side Effects | Nausea, abdominal pain, diarrhea, decreased appetite, vomiting |
| Serious Side Effects | Pancreatitis, gallbladder disease, hypoglycemia, acute kidney injury, hypersensitivity |
| Limitations | Not for type 1 diabetes; not studied in patients with pancreatitis history |
| Long-Term Data | Long-term cardiovascular safety established |
| Storage | -20°C (lyophilized); 2-8°C (reconstituted) |
| Advantage | Why It Matters |
|---|---|
| Lab-Verified >98% Purity | Third-party HPLC testing ensures quality and consistency |
| 5mg & 10mg Options | Flexible dosing for various research protocols |
| COA Included | Full transparency with every Liraglutide order |
| Fast Shipping | Orders processed within 24 hours (shipped with ice pack) |
| Discreet Packaging | Privacy guaranteed |
Liraglutide is supplied for research and laboratory use only. Not for human consumption. Not for therapeutic or diagnostic use. Use only by qualified researchers in controlled laboratory settings. Not FDA-approved for human use outside approved clinical protocols.
| Weight | 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg, 5×200 mg |
|---|
Always available!
Comes with each order!
Get access to expert resources.
Reviews
There are no reviews yet.